EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Absence of Viral Replication Is Associated With Improved Outcome in Anti‐ HCV ‐Positive Patients With Hepatocellular Carcinoma

Edoardo G Giannini iD, Andrea Pasta iD, Maria Corina Plaz Torres iD, Giulia Pieri iD, Giuseppe Cabibbo iD, Angelo Sangiovanni iD, Fabio Piscaglia iD, Claudia Campani iD, Gabriele Missale iD, Gianpaolo Vidili iD, Giorgia Ghittoni iD, Filippo Pelizzaro iD und 19 weitere

Liver International · 2025

DOI: 10.1111/liv.16185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Edoardo G Giannini und 30 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Sustained Virologic Response. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Presence of active hepatitis C virus (HCV) infection may influence the outcome of patients treated for hepatocellular carcinoma (HCC), although this issue has never been adequately assessed in a large series of patients. The aim of this study was to evaluate whether the presence of active HCV affects the survival of patients treated for HCC.

Methods

This study assessed the outcome of 3123 anti‐HCV‐positive patients with HCC, subdivided according to the presence of active HCV infection or previous sustained virological response (SVR). Comparisons were also carried out after propensity score matching (PSM) considering demographic, clinical and oncological characteristics.

Results

The median overall survival from HCC treatment was longer in patients with SVR than in those with active HCV infection both before ( n = 2118: 61.0 months [95% confidence internal (CI): 56.5–65.5] vs. n = 1005: 51.0 months [95% CI: 43.4–58.6]; p = 0.003) and after PSM ( n = 1285: 60.0 months [95% CI: 55.3–64.7] vs. n = 926: 54.0 months [95% CI: 46.7–61.3]; p = 0.030). Active HCV infection was associated with a greater risk of mortality (hazard ratio: 1.22–1.27, p = 0.001) independently of liver‐ and tumour‐related variables, and modality of HCC treatment. Death due to liver failure was more common in patients with active HCV infection (24.5% vs. 17.1%; p = 0.001), while non‐liver‐related causes of death were more common in patients with SVR (25.0% vs. 17.0%; p = 0.001).

Conclusions

SVR is associated with a better outcome in patients undergoing HCC treatment, thus suggesting that these patients may benefit from antiviral therapy for HCV independently of cure of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntiviral AgentsSustained Virologic ResponseHepacivirusPropensity ScoreVirus ReplicationHumansMaleFemaleMiddle AgedAgedRetrospective StudiesHepatitis C, ChronicTreatment Outcome

Stichwörter der Autor:innen

direct‐acting antiviralsoutcomeresponsesurvivaltreatment

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Gastroenterology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Gastroenterology & Hepatology Unit, Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, University of Palermo, Palermo, Italy.
  • Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale maggiore Policlinico and C.R.C. "A.M. & A. Migliavacca Center for Liver Disease", Milan, Italy.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

ORCID-Profile: Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, Giulia Pieri, Giuseppe Cabibbo, Angelo Sangiovanni, Fabio Piscaglia, Claudia Campani, Gabriele Missale, Gianpaolo Vidili, Giorgia Ghittoni, Filippo Pelizzaro, Francesco Giuseppe Foschi, Filomena Morisco, Valentina Santi, Gianluca Svegliati-Baroni, Francesco Azzaroli, Carlo Saitta, Maurizia Rossana Brunetto, Rodolfo Sacco, Francesca Romana Ponziani, Gerardo Nardone, Andrea Martini, Andrea Mega, David Sacerdoti, Donatella Magalotti, Alessandro Vitale, Laura Bucci, Franco Trevisani

Zitieren

APA

Giannini, E. G., Pasta, A., Plaz Torres, M. C., Pieri, G., Cabibbo, G., Sangiovanni, A., Piscaglia, F., Campani, C., Missale, G., Vidili, G., Ghittoni, G., Pelizzaro, F., Foschi, F. G., Morisco, F., Santi, V., Svegliati-Baroni, G., Azzaroli, F., Saitta, C., Brunetto, M. R., …, & Italian Liver Cancer (ITA.LI.CA) group (2025). Absence of Viral Replication Is Associated With Improved Outcome in Anti‐ HCV ‐Positive Patients With Hepatocellular Carcinoma. Liver International. https://doi.org/10.1111/liv.16185

Vancouver

Giannini EG, Pasta A, Plaz Torres MC, Pieri G, Cabibbo G, Sangiovanni A, et al. Absence of Viral Replication Is Associated With Improved Outcome in Anti‐ HCV ‐Positive Patients With Hepatocellular Carcinoma. Liver International. 2025. doi:10.1111/liv.16185

BibTeX
@article{Giannini2025,
  author = {Giannini, Edoardo G and Pasta, Andrea and Plaz Torres, Maria Corina and Pieri, Giulia and Cabibbo, Giuseppe and Sangiovanni, Angelo and Piscaglia, Fabio and Campani, Claudia and Missale, Gabriele and Vidili, Gianpaolo and Ghittoni, Giorgia and Pelizzaro, Filippo and Foschi, Francesco Giuseppe and Morisco, Filomena and Santi, Valentina and Svegliati-Baroni, Gianluca and Azzaroli, Francesco and Saitta, Carlo and Brunetto, Maurizia Rossana and Sacco, Rodolfo and Ponziani, Francesca Romana and Boninsegna, Sara and Nardone, Gerardo and Martini, Andrea and Mega, Andrea and Sacerdoti, David and Magalotti, Donatella and Vitale, Alessandro and Bucci, Laura and Trevisani, Franco and Italian Liver Cancer (ITA.LI.CA) group, Italian Liver Cancer (ITA.LI.CA) group},
  title = {Absence of Viral Replication Is Associated With Improved Outcome in Anti‐ HCV ‐Positive Patients With Hepatocellular Carcinoma},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16185}
}
Kostenlos starten →